The Institute of Cancer and Crisis (ICC) shared CancerWorld’s post on LinkedIn, adding:
“We are delighted to announce the official launch of OncoCorridor – taking place May 18 in Geneva alongside the World Health Assembly.
Led by OncoDaily and The Institute of Cancer and Crisis (ICC), OncoCorridor will serve as a first-of-its-kind global network tackling the ‘last mile’ challenge faced by cancer patients in conflict zones.
Life-saving treatments exist – but there is currently no coordinated global system to ensure patient evacuation and continuity of care.
Until now!
Join us in Geneva as we take the first step toward changing that.
Please share to spread the word.”
Quoting CancerWorld’s post:
“OncoCorridor
editorial by Gevorg Tamamyan
We are trained to deliver bad news:
‘You have cancer… but there is a chance to be cured.’
But what do you say in a war zone?
‘Your child has leukemia. It is curable, but there is no hospital, no chemotherapy, no access to treatment.’
Medicine has answers.
War removes access.
Every year, advances in oncology save lives. At the same time, patients in conflict zones are left behind not because treatments do not exist, but because they cannot be reached.
This is not a medical gap. It is a systems failure.
On May 18, in Geneva, during the World Health Assembly, OncoDaily, together with the Institute of Cancer and Crisis, will launch OncoCorridor — a global initiative designed to connect cancer patients in conflict-affected regions with treatment centers worldwide.
Because no one should die from a curable cancer due to war.
We know what to do.
Now we must deliver.
Read the full CancerWorld cover story by Gevorg Tamamyan.”
More posts about OncoCorridor.